Five things for pharma marketers to know: Thursday, May 24, 2018

Recro non-opioid injection receives complete response letter from FDA; Pfizer settles False Claims Act allegations; Medtronic reports better-than-expected profit.

from Most popular articles from Medical Marketing and Media https://ift.tt/2saYfEa